Bellerophon to Present Clinical Data Supporting Actigraphy as a Clinically Meaningful Endpoint Biotech Investing
MacroGenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA Pharmaceutical Investing
Life Science Big News Roundup: Makers of Malboro Fund Lexaria’s Oral Nicotine Project; NanoSphere Signs Licensing Agreement with Delta 9 Cannabis Inc. Biotech Investing
